Russia registers nasal model of Sputnik V, world’s first nasal vaccine towards COVID-19

The Russian information company TASS in January reported that the nasal vaccine will probably be in civil circulation and obtainable for Russians inside 3-4 months, quoting the director of the Gamaleya Centre, Alexander Gintsburg.

The first consignment of imported doses of the Sputnik V vaccine landed in India on May 1, 2021 (File)

The Russian Health Ministry has registered the nasal model of its vaccine towards coronavirus – Sputnik V. It is the world’s first nasal vaccine towards COVID-19.

The Russian information company TASS in January reported that the nasal vaccine towards the novel coronavirus an infection will probably be in civil circulation and obtainable for Russians inside 3-4 months, quoting the director of the Gamaleya Centre, Alexander Gintsburg. The Gamalaya Centre, a analysis institute, is the producer of Sputnik V.

In October 2021, the Russian well being ministry licensed the second part scientific trials of the coronavirus vaccine within the nasal spray type.

“Laboratory assessments present the Sputnik V protects towards Omicron in its strange injection type, and it’ll actually be environment friendly within the nasal type,” Gintsburg informed TASS.

The Sputnik V coronavirus vaccine was administered first in India in Hyderabad in May 2021. The first consignment of imported doses of the Sputnik V vaccine landed in India on May 1, and obtained regulatory clearance from the Central Drugs Laboratory on May 13, 2021.

Also Read: | Will Russian invasion of Ukraine have an effect on Sputnik V vaccine’s manufacturing?